2bind and Jena Bioscience Announce Collaboration for Enhanced Antibody Formulation Development

2bind GmbH, a leading provider of biophysical analysis tools, is pleased to announce a new collaboration with Jena Bioscience GmbH, a renowned manufacturer of high-quality reagents and tools for life science research. This partnership brings together the expertise of both companies to enhance antibody formulation development with the FORMOscreen®.

Within this collaboration, Jena Bioscience GmbH will manufacture the FORMOscreen® under ISO 9001 quality standards, ensuring the highest level of quality and consistency for researchers. The FORMOscreen® is a key component of the 2bind BufferToolbox® series, which offers researchers simple and cost-effective access to advanced formulation development for proteins and antibodies.

“We are delighted to have acquired Jena Bioscience GmBbH as a production partner to elevate the FORMOscreen® to new standards of accessibility,” said Dr. Maximilian Plach, COO at 2bind. “This collaboration allows us to leverage Jena Bioscience’s manufacturing expertise while focusing on developing innovative solutions for our customers in the field of biophysical analysis.”

The FORMOscreen® enables rapid characterization of antibodies in 96 pre-made buffer conditions, derived from formulations of therapeutic antibodies approved by the FDA and EMA. This powerful tool accelerates formulation development by providing researchers with a standardized and efficient platform for screening optimal buffer conditions.

The FORMOscreen® is now available through Jena Bioscience or from 2bind’s webshop. For more information about the FORMOscreen® and the 2bind BufferToolbox® series, please visit:

https://shop.2bind.com/

https://www.jenabioscience.com/crystallography-cryo-em/screening/solubility-stability-screens/formoscreen/cs-360-formoscreen

Get In Touch